U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 5,803 records

Showing results for "stimulants".

  1. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
    February 02, 2012 - Most studies that compared behavior therapy to stimulants found a much stronger ef­ fect on ADHD core … symptoms from stimulants than from behavior ther­ apy. … with less frequent monitoring and had less optimal re­ sults.65 Because stimulants might pro­ duce … Because stimulant medication effects are seen immediately, trials of different doses of stimulants … Illicit use of psycho- stimulants among college students: a pre­ liminary study.

  2. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
    February 02, 2012 - An un- common additional significant ad- verse effect of stimulants is the occur- rence of hallucinations … Most studies that compared behavior therapy to stimulants found a much stronger ef- fect on ADHD core … symptoms from stimulants than from behavior ther- apy. … Because stimulant medication effects are seen immediately, trials of different doses of stimulants can … Illicit use of psycho- stimulants among college students: a pre- liminary study.

  3. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
    February 02, 2012 - Most studies that compared behavior therapy to stimulants found a much stronger ef­ fect on ADHD core … symptoms from stimulants than from behavior ther­ apy. … with less frequent monitoring and had less optimal re­ sults.65 Because stimulants might pro­ duce … Because stimulant medication effects are seen immediately, trials of different doses of stimulants … Illicit use of psycho- stimulants among college students: a pre­ liminary study.

  4. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
    February 02, 2012 - An un- common additional significant ad- verse effect of stimulants is the occur- rence of hallucinations … Most studies that compared behavior therapy to stimulants found a much stronger ef- fect on ADHD core … symptoms from stimulants than from behavior ther- apy. … Because stimulant medication effects are seen immediately, trials of different doses of stimulants can … Illicit use of psycho- stimulants among college students: a pre- liminary study.

  5. Agency for Healthcare Research and Quality

    www.ahrq.gov/research/findings/studies/index.html?page=21
    January 01, 2024 - Burgette JM Trends in dispensed prescriptions for opioids, sedatives, benzodiazepines, gabapentin, and stimulants … This study examined trends in prescription fills for opioids, benzodiazepines, gabapentin, and stimulants … high-alert prescriptions, however from 2012 to 2019 fills for opioids, sedatives, benzodiazepines, and stimulants … Trends in dispensed prescriptions for opioids, sedatives, benzodiazepines, gabapentin, and stimulants

  6. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications - 2012 | Digital Healthcare Research

    digital.ahrq.gov/ahrq-funded-projects/enabling-electronic-prescribing-and-enhanced-management-controlled-medications/annual-summary/2012
    January 01, 2012 - of electronic prescribing (e-prescribing) to cover federally controlled substances (e.g., narcotics, stimulants

  7. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications | Digital Healthcare Research

    digital.ahrq.gov/ahrq-funded-projects/enabling-electronic-prescribing-and-enhanced-management-controlled-medications
    January 01, 2022 - standards for the electronic prescribing of federally controlled substances (EPCS) (e.g., narcotics, stimulants

  8. Table 1 (pdf file)

    hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/TableofChanges2016_2.pdf
    January 01, 2016 - Table 1 Table of Changes Made to Comorbidity Software for ICD-10-CM for Version 2016.2 ICD-10-CM Changes to the Comorbidity Software ICD-10-CM Diagnosis Code ICD-10-CM Diagnosis Code Label Comorbidity Assignment F11121 Opioid abuse with intoxication delirium DRUG F11150 Opioid abuse wi…

  9. Table 1 (pdf file)

    hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/TableofChanges2017_2.pdf
    January 01, 2017 - Table 1 Table of Changes Made to Comorbidity Software for ICD-10-CM for Version 2017.2 ICD-10-CM Changes to the Comorbidity Software ICD-10-CM Diagnosis Code ICD-10-CM Diagnosis Code Label Comorbidity Assignment F11121 Opioid abuse with intoxication delirium DRUG F11150 Opioid abuse wi…

  10. Opioid-Related and Stimulant-Related Adult Inpatient Stays, 2012-2018 #271

    hcup-us.ahrq.gov/reports/statbriefs/sb271-Stimulant-Opioid-Hospitalizations-2012-2018.jsp
    January 01, 2018 - Opioid-Related and Stimulant-Related Adult Inpatient Stays, 2012-2018

  11. Attachment 3.1 References (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-iii-a.pdf
    January 01, 2014 - Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder

  12. Attachment 3.1 References (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-iii-a.pdf
    January 01, 2014 - Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder

  13. Attachment 3.1 References (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-iii-a.pdf
    January 01, 2014 - Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder

  14. Attachment 3.1 References (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-iii-a.pdf
    January 01, 2014 - Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder

  15. Attachment 3.1 References (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-iii-a.pdf
    January 01, 2014 - Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder

  16. Attachment 3.1 References (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-iii-a.pdf
    January 01, 2014 - Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder

  17. Attachment 3.1 References (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-iii-a.pdf
    January 01, 2014 - Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder

  18. Ideas to Innovation: Stimulating Collaborations in the Application of Resilience Engineering to Healthcare. | PSNet

    psnet.ahrq.gov/issue/ideas-innovation-stimulating-collaborations-application-resilience-engineering-healthcare
    April 24, 2013 - Audiovisual Slideset Published April 24, 2013 Ideas to Innovation: Stimulating Collaborations in the Application of Resilience Engineering to Healthcare. Medstar Healthcare; University-Industry Demonstration Partnership;…

  19. Appendix - Adverse Drug Events in U.S. Hospitals, 2010 Versus 2014 (pdf file)

    hcup-us.ahrq.gov/reports/statbriefs/sb234-appendix.pdf
    January 01, 2014 - analeptics 970.1 Poisoning by opiate antagonists 970.8 Poisoning by other specified central nervous system stimulants … 970.81 Poisoning by cocaine 970.89 Poisoning by other central nervous system stimulants 970.9 Poisoning … unspecified central nervous system stimulant E854.3 Accidental poisoning by central nervous system stimulants … antagonists causing adverse effects in therapeutic use E940.8 Other specified central nervous system stimulants

  20. New Interactive Data Map Shows Extent of Leading Mental Disorders in the United States | Agency for Healthcare Research and Quality

    www.ahrq.gov/news/newsletters/e-newsletter/866.html
    May 01, 2023 - Trends in dispensed prescriptions for opioids, sedatives, benzodiazepines, gabapentin, and stimulants
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

ecareplan.ahrq.gov (1341)

psnet.ahrq.gov (732)

effectivehealthcare.ahrq.gov (545)

www.ahrq.gov (495)

cmext.ahrq.gov (432)

ce.effectivehealthcare.ahrq.gov (294)

hcup-us.ahrq.gov (211)

www.qualitymeasures.ahrq.gov (159)

digital.ahrq.gov (158)

srdr.ahrq.gov (143)

www.uspreventiveservicestaskforce.org (118)

www.talkingquality.ahrq.gov (117)

www.innovations.ahrq.gov (111)

www.monahrq.ahrq.gov (111)

www.healthcare411.ahrq.gov (108)

www.cahps.ahrq.gov (106)

www.cpsi.ahrq.gov (82)

pcmh.ahrq.gov (66)

pbrn.ahrq.gov (61)

monahrq.ahrq.gov (53)

cahps.ahrq.gov (52)

healthcare411.ahrq.gov (51)

patientregistry.ahrq.gov (46)

talkingquality.ahrq.gov (45)

ahrqpubs.ahrq.gov (43)

preventiveservices.ahrq.gov (41)

teamstepps.ahrq.gov (33)

meps.ahrq.gov (25)

qualityindicators.ahrq.gov (6)

srdrplus.ahrq.gov (5)

cds.ahrq.gov (4)

cdsic.ahrq.gov (3)

datatools.ahrq.gov (2)

hcupnet.ahrq.gov (2)

covid-acts.ahrq.gov (1)

pso.ahrq.gov (1)